Home | Drugs Approvals and Trials

Drugs Approvals and Trials

Human trial begins on health benefits of seaweed fibre

World first human trial to determine if seaweed can help chronic disorders such as Type 2 Diabetes. ...

FDA approves first Factor X concentrate to treat patients with rare hereditary bleeding disorder

The U.S. Food and Drug Administration today approved Coagadex, Coagulation Factor X (Human), for hereditary Factor X (10) deficiency. Until today’s orphan ...

FDA approves new injectable drug to treat schizophrenia

On October 5, the U.S. Food and Drug Administration approved Aristada (aripiprazole lauroxil) extended release injection to treat adults with schizophrenia. Aristada is administered by a health care professional every four to six weeks using an injection in the arm or buttocks. ... Full story

Tasmania to trial an epilepsy world first

Tasmanians living with or affected by epilepsy will soon benefit from a world-first telephone-based peer support service delivered in a partnership between the University of Tasmania and Epilepsy Tasmania. ... Full story

Clinical trial for Cardiff’s shingles treatment

The first ever patient has been enrolled in the pivotal phase III clinical trial of a drug pioneered by the University which could bring hope for millions of shingles sufferers ... Full story

FDA approves new drug treatment for nausea and vomiting from chemotherapy

The U.S. Food and Drug Administration approved Varubi (rolapitant) to prevent delayed phase chemotherapy-induced nausea and vomiting (emesis). Varubi is approved in adults in combination with other drugs (antiemetic agents) that prevent nausea and vomiting associated with initial and repeat courses of vomit-inducing (emetogenic and highly emetogenic) cancer chemotherapy. ... Full story

FDA approves Repatha to treat certain patients with high cholesterol

The U.S. Food and Drug Administration today approved Repatha (evolocumab) injection for some patients who are unable to get their low-density lipoprotein (LDL) cholesterol under control with current treatment options. ... Full story

Study Finds Tests Used to Measure Internal Bleeding For Patients Taking Two Popular Drugs May Not Be Reliable

A recently-published study found that while internal bleeding may be uncommon as a result of taking blood thinners such as Xarelto® (rivaroxaban) and Eliquis® (apixaban), the normal coagulation tests physicians use to check for the side effect of bleeding may not be reliable. ... Full story

Patient-Funded Trials May Do More Harm Than Good, Ethicists Warn

In the era of launching Kickstarter campaigns to pay for just about anything, Carnegie Mellon University ethicists warn that the trend of patients funding their own clinical trials may do more harm than good. ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 540 | displaying: 1 - 10